Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

Eli Lilly highlighted 2025 as the rollout year for obesity drugs, with Mounjaro at the forefront of its weight-loss portfolio ...

Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...

Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its ...

After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...

Delaware Attorney General Kathy Jennings is suing several drug manufacturers and pharmacy benefit managers for reported ...

Betty Remedios, 63, has a pep in her step as she gets out of the horizontal cylinder in which she’s been getting ...

Metformin is the first choice medicine for type 2 diabetes. Meglitinides can cause low blood sugar, weight gain, and headaches. Biguanides can cause stomach pain and might lead to vitamin B12 ...

Anyone who's been prescribed a GLP-1 drug like Ozempic, Wegovy or Trulicity to treat type 2 diabetes or help them lose weight ...

The robbery unfolded outside Smart Choice Pharmacy on Street Road, where police say the suspects ambushed a driver delivering medications. Investigators said the three men used physical force to steal ...

Monday, January 12, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...